Want to join the conversation?
$BIIB 2Q15 Call: In Hemophilia, ALPROLIX revenue was $54MM and ELOCTATE revenues was $74MM. R&D expense was $491MM, or 19% of revenue. SG&A expense was $492MM or 19% of revenue. Weighted avg. diluted shares at 2Q15-end were 236MM. Revenue estimate for the rest of MS portfolio remain unchanged. OpEx as a percentage of sales remains unchanged.
Planned to give Apple AirPods as a Christmas present to my beloved one. Looks like I need backup plans as $AAPL is delaying the release..!!
When you fall hard, I think you stay there for a long time.. I am looking at you $FTNT! After it released the earnings, the share price slipped and is staying around $30 for a long time.
$FOXA just entered into a preliminary deal with Sky plc under which it will acquire all shares, or should I say remaining shares for a total value of $23 billion. The sleeping fox catches no poultry, but this fox just caught something that’s a lot bigger than poultry.